Needle-free drug delivery funding

Micron Biomedical, who develop dissolvable, microarray-based products to simplify the delivery of drugs and vaccines, have announced that they have added $3m to its Series A, bringing the total funding to $17m.

Micron said its Series A extension further supports efforts to bring its drug delivery technology to market. It said its focus centers around national health security and meeting needs of underserved populations. Its patented microarray technology enables the administration of drugs and vaccines that require cold storage and administration within minutes. It can be self-administered or caregiver-administered. The technology simplifies transport, storage and administration while eliminating traditional injection sharps waste. Completed trials demonstrated clinical efficacy and strong patient preference, according to the company.

To read more, CLICK HERE.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags